0001104659-22-012937.txt : 20220207
0001104659-22-012937.hdr.sgml : 20220207
20220207205903
ACCESSION NUMBER: 0001104659-22-012937
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220207
FILED AS OF DATE: 20220207
DATE AS OF CHANGE: 20220207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murphy-Chutorian Douglas
CENTRAL INDEX KEY: 0001594342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36305
FILM NUMBER: 22599084
MAIL ADDRESS:
STREET 1: C/O SEMLER SCIENTIFIC, INC.
STREET 2: 911 BERN COURT, SUITE 110
CITY: SAN JOSE
STATE: CA
ZIP: 95112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Semler Scientific, Inc.
CENTRAL INDEX KEY: 0001554859
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 261367393
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
BUSINESS PHONE: 408-627-4557
MAIL ADDRESS:
STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
4
1
tm225807d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2022-02-07
0
0001554859
Semler Scientific, Inc.
SMLR
0001594342
Murphy-Chutorian Douglas
C/O SEMLER SCIENTIFIC, INC.
2340-2348 WALSH AVENUE, SUITE 2344
SANTA CLARA
CA
95051
1
1
1
0
Chief Executive Officer
Common Stock
2022-02-07
4
M
0
2000
2.10
A
2000
D
Common Stock
2022-02-07
4
S
0
647
77.6798
D
1353
D
Common Stock
2022-02-07
4
S
0
743
78.4728
D
610
D
Common Stock
2022-02-07
4
S
0
510
79.8784
D
100
D
Common Stock
2022-02-07
4
S
0
100
81.4850
D
0
D
Stock Option (right to buy)
2.10
2022-02-07
4
M
0
2000
0
D
2024-11-08
Common Stock
2000
77000
D
Shares sold pursuant to a 10b5-1 trading plan adopted by the reporting person on December 7, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.14 to $78.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 3 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.19 to $79.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.60 to $80.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
The shares underlying the option are fully vested and immediately exercisable.
/s/ Daniel E. Conger, Attorney-in-fact
2022-02-07